| New Delhi |
Updated: October 24, 2020 7:52:13 am
BHARAT BIOTECH, which has received approval for late-stage human trials for its Covid vaccine candidate, expects to have it ready by June 2021 — unless the government advances its launch through emergency use authorisation, according to a top company official.
The Hyderabad-based firm plans to test over 20,000 volunteers across 12-14 states for Covaxin, its indigenous candidate, Sai Prasad, executive director, Bharat Biotech International Ltd, told The Indian Express.
“If we get all the…